secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001104659-25-059950
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics stockholders elect two Class I directors and ratify E&Y as auditor at annual meeting
--------------------------------------------------------------------------------

- Daphne Quimi elected with 52,593,454 votes for; Carlo Rizzuto elected with 51,373,990 votes for.
- Ratification of Ernst & Young LLP as independent auditor for 2025 passed with 71,768,193 votes for.
- Broker non-votes of 15,072,004 on director elections; no broker non-votes on auditor ratification.
- Annual meeting held virtually on June 12, 2025; record date April 16, 2025 with 86,158,758 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925059950/0001104659-25-059950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925059950/tm2518111d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-059950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer